Data as of Apr 16
| +0.1065 / +7.59%|
The 1 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +297.35% increase from the last price of 1.51.
The current consensus among 1 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.